Buy & Sell Equinix Inc (EQIX) – Equinix Inc Price Today
Aura AI Summary
Key Stats
- $107.30BMarket Cap
- Real EstateSector
- -4.35%3M Drawdown
- $127.58BEnterprise Value
- 1.81%Dividend Yield
- 99% Buy | 1% SellTrading Activity
- 103 daysTypical Hold Time
Equinix Inc (EQIX) is currently valued at a market capitalization of $107.30B, with an enterprise value of $127.58B. Over the past 52 weeks, Equinix Inc has traded between a low of $726.09 and a high of $1,115.29, highlighting its annual price range. Over the past three months, Equinix Inc has recorded a drawdown of -4.35%, reflecting recent price volatility. Equinix Inc offers a dividend yield of 1.81%, with the most recent dividend of $5.16 paid on 25 Feb 26. On average, investors hold Equinix Inc for approximately 103 days, indicating typical investor behavior on the platform.
About Equinix Inc
Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.
Most Recent News
Wrap Technologies to showcase non-lethal BolaWrap system at European law enforcement event in Italy
Wrap Technologies will present its non-lethal BolaWrap device, immersive WrapReality training, and policy strategies at a European law enforcement conference in Italy on May 13-14, 2026. The event aims to introduce safer, modern public safety tools t...
FDA agrees on two clearance pathways for BioCardia's Helix delivery catheter, favoring simultaneous CardiAMP therapy approval.
BioCardia announced that the FDA agreed on two possible marketing clearance pathways for its Helix Transendocardial Delivery Catheter System, with no safety or performance concerns raised. The FDA's preferred approval route is simultaneous with the C...
US Treasury may borrow over $2 trillion in fiscal 2026 amid rising debt and costs.
The US Treasury plans to borrow more than $2 trillion from private markets in fiscal year 2026, driven by a projected $2.065 trillion deficit and rising national debt nearing $39 trillion. Borrowing needs are expected to stay above $2 trillion throug...
